PROTEÍNA ANTAGONISTA DEL RECEPTOR DE LA INTERLEUQUINA-1 (IRAP) PARA EL TRATAMIENTO DE ENFERMEDADES ARTICULARES EN LOS CABALLOS DE CARRERAS PROTEIN ANTAGONIST OF INTERLEUKIN-1 RECEPTOR FOR THE TREATMENT OF JOINT DISEASES IN RACEHORSES

Currently, there are numerous techniques described for the treatment of joint diseases in racehorses. Nevertheless, all of these show certain limitations. Interleukin-1 is a citoquin that plays an important role in the deterioration of the skeletal muscle structures due to its powerful inflammatory action. Due to this, the use of the protein antagonist of the interleukin1 receptor (IRAP) manages to drastically decrease the pain and the inflammation of the